These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 10900217)

  • 1. Evaluation of selective NK(1) receptor antagonist CI-1021 in animal models of inflammatory and neuropathic pain.
    Gonzalez MI; Field MJ; Hughes J; Singh L
    J Pharmacol Exp Ther; 2000 Aug; 294(2):444-50. PubMed ID: 10900217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antinociceptive activity of the N-methyl-D-aspartate receptor antagonist N-(2-Indanyl)-glycinamide hydrochloride (CHF3381) in experimental models of inflammatory and neuropathic pain.
    Villetti G; Bergamaschi M; Bassani F; Bolzoni PT; Maiorino M; Pietra C; Rondelli I; Chamiot-Clerc P; Simonato M; Barbieri M
    J Pharmacol Exp Ther; 2003 Aug; 306(2):804-14. PubMed ID: 12750440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gabapentin and the neurokinin(1) receptor antagonist CI-1021 act synergistically in two rat models of neuropathic pain.
    Field MJ; Gonzalez MI; Tallarida RJ; Singh L
    J Pharmacol Exp Ther; 2002 Nov; 303(2):730-5. PubMed ID: 12388658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of the central tachykinin NK1 receptor during maintenance of mechanical hypersensitivity induced by diabetes in the rat.
    Field MJ; McCleary S; Boden P; Suman-Chauhan N; Hughes J; Singh L
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1226-32. PubMed ID: 9618426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of (S)-3,4-DCPG, an mGlu8 receptor agonist, on inflammatory and neuropathic pain in mice.
    Marabese I; de Novellis V; Palazzo E; Scafuro MA; Vita D; Rossi F; Maione S
    Neuropharmacology; 2007 Feb; 52(2):253-62. PubMed ID: 17113112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent antihyperalgesic activity without tolerance produced by glycine site antagonist of N-methyl-D-aspartate receptor GV196771A.
    Quartaroli M; Carignani C; Dal Forno G; Mugnaini M; Ugolini A; Arban R; Bettelini L; Maraia G; Belardetti F; Reggiani A; Trist DG; Ratti E; Di Fabio R; Corsi M
    J Pharmacol Exp Ther; 1999 Jul; 290(1):158-69. PubMed ID: 10381772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioural effects of the novel AMPA/GluR5 selective receptor antagonist NS1209 after systemic administration in animal models of experimental pain.
    Blackburn-Munro G; Bomholt SF; Erichsen HK
    Neuropharmacology; 2004 Sep; 47(3):351-62. PubMed ID: 15275824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The roles of different subtypes of opioid receptors in mediating the nucleus submedius opioid-evoked antiallodynia in a neuropathic pain model of rats.
    Wang JY; Zhao M; Yuan YK; Fan GX; Jia H; Tang JS
    Neuroscience; 2006; 138(4):1319-27. PubMed ID: 16472929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gabapentin (neurontin) and S-(+)-3-isobutylgaba represent a novel class of selective antihyperalgesic agents.
    Field MJ; Oles RJ; Lewis AS; McCleary S; Hughes J; Singh L
    Br J Pharmacol; 1997 Aug; 121(8):1513-22. PubMed ID: 9283683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The VR1 antagonist capsazepine reverses mechanical hyperalgesia in models of inflammatory and neuropathic pain.
    Walker KM; Urban L; Medhurst SJ; Patel S; Panesar M; Fox AJ; McIntyre P
    J Pharmacol Exp Ther; 2003 Jan; 304(1):56-62. PubMed ID: 12490575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. mu- but not delta- and kappa-opioid receptors in the ventrolateral orbital cortex mediate opioid-induced antiallodynia in a rat neuropathic pain model.
    Zhao M; Wang JY; Jia H; Tang JS
    Brain Res; 2006 Mar; 1076(1):68-77. PubMed ID: 16476416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of antinociceptive actions of standard analgesics in attenuating capsaicin and nerve-injury-induced mechanical hypersensitivity.
    Joshi SK; Hernandez G; Mikusa JP; Zhu CZ; Zhong C; Salyers A; Wismer CT; Chandran P; Decker MW; Honore P
    Neuroscience; 2006 Dec; 143(2):587-96. PubMed ID: 16962719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuation of morphine tolerance by minocycline and pentoxifylline in naive and neuropathic mice.
    Mika J; Wawrzczak-Bargiela A; Osikowicz M; Makuch W; Przewlocka B
    Brain Behav Immun; 2009 Jan; 23(1):75-84. PubMed ID: 18684397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A role for cannabinoid receptors, but not endogenous opioids, in the antinociceptive activity of the CB2-selective agonist, GW405833.
    Whiteside GT; Gottshall SL; Boulet JM; Chaffer SM; Harrison JE; Pearson MS; Turchin PI; Mark L; Garrison AE; Valenzano KJ
    Eur J Pharmacol; 2005 Dec; 528(1-3):65-72. PubMed ID: 16316650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analgesic activity of ZC88, a novel N-type voltage-dependent calcium channel blocker, and its modulation of morphine analgesia, tolerance and dependence.
    Meng G; Wu N; Zhang C; Su RB; Lu XQ; Liu Y; Yun LH; Zheng JQ; Li J
    Eur J Pharmacol; 2008 May; 586(1-3):130-8. PubMed ID: 18374913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spinal administration of a delta opioid receptor agonist attenuates hyperalgesia and allodynia in a rat model of neuropathic pain.
    Holdridge SV; Cahill CM
    Eur J Pain; 2007 Aug; 11(6):685-93. PubMed ID: 17175187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A-740003 [N-(1-{[(cyanoimino)(5-quinolinylamino) methyl]amino}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide], a novel and selective P2X7 receptor antagonist, dose-dependently reduces neuropathic pain in the rat.
    Honore P; Donnelly-Roberts D; Namovic MT; Hsieh G; Zhu CZ; Mikusa JP; Hernandez G; Zhong C; Gauvin DM; Chandran P; Harris R; Medrano AP; Carroll W; Marsh K; Sullivan JP; Faltynek CR; Jarvis MF
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1376-85. PubMed ID: 16982702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antinociceptive and antihyperalgesic effects of tapentadol in animal models of inflammatory pain.
    Schiene K; De Vry J; Tzschentke TM
    J Pharmacol Exp Ther; 2011 Nov; 339(2):537-44. PubMed ID: 21816956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological characterization of the chronic constriction injury model of neuropathic pain.
    De Vry J; Kuhl E; Franken-Kunkel P; Eckel G
    Eur J Pharmacol; 2004 May; 491(2-3):137-48. PubMed ID: 15140630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antinociceptive effects and toxicity of morphine-6-O-sulfate sodium salt in rat models of pain.
    Holtman JR; Crooks PA; Johnson-Hardy J; Wala EP
    Eur J Pharmacol; 2010 Dec; 648(1-3):87-94. PubMed ID: 20828549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.